"Better safe than sorry."
Congratulations to Bio Preventive Medicine Corp. for their innovative kidney disease test kit, DNlite-IVD103, granted TFDA approval!
This breakthrough benefits diabetic patients by predicting disease progression two years in advance, potentially saving billions in healthcare costs. It's a pioneering step in Taiwan's IVD sector, marking the first international foray into chronic disease healthcare. Read more: https://news.gbimonthly.com/tw/article/show.php?num=64123
Follow #Globalbio for more updates!
#BioPreventiveMedicine #MedicalInnovation #DiabetesAwareness #TFDAApproval #IVD #HealthTec
Bio Preventive Medicine Corp.'s DNlite-IVD103 granted TFDA approval
下一篇